Los Angeles: The US government is launching a program spending more than $5 billion to accelerate the development of new coronavirus vaccines and treatments to better protect against current and future Covid variants. According to the report, Project Next The program, called Generation, will allow the government to partner with private sector companies to accelerate the development of vaccines and treatments.
According to The Washington Post, the new effort will focus on three goals. First- making long-lasting monoclonal antibodies. The second is to accelerate the development of vaccines that generate mucosal immunity, which is believed to reduce the risk of transmission and infection. Third – to accelerate efforts to develop a vaccine effective on all variants to protect against the new SARS-CoV2 variant as well as other corona viruses.
It is clear that the market is moving very slowly on this, Ashish Jha, the White House’s coronavirus coordinator, said on Monday. There’s a lot that the government can do, the administration can do, to get those tools up to speed for the American people. Jha said investing in next-generation coronavirus vaccines could have a beneficial impact on the health system. “Our ability to create a vaccine that generates mucosal immunity will be of great benefit in the fight against other respiratory pathogens that we deal with all the time, such as flu and RSV,” he said. Some lab work is underway, and the US government has begun efforts to find potential private sector partners, according to Don O’Connell, assistant secretary for preparedness and response at the US Department of Health and Human Services.
Read the latest news about banking, economy and economic affairs on The Eastern Herald .
